The cancer medication Casodex (bicalutamide) comes in both brand-name and generic form. Regardless of the form you choose, it comes in just one strength: 50-mg tablets. The FDA considers all of the generic forms equivalent to the brand-name drug. Some of the companies that make a generic version include Teva Pharmaceuticals, Sandoz, and Sun Pharmaceutical Global, Inc.
Casodex® (bicalutamide) is a prescription medication used as part of combination treatment for advanced prostate cancer. It belongs to a group of medicines called androgen receptor inhibitors, or simply "antiandrogens."
Brand-name Casodex is made by IPR Pharmaceuticals, Inc., for AstraZeneca Pharmaceuticals LP. It is available in generic form.
Generic Casodex is available in one strength and form -- Bicalutamide 50 mg tablets.
Generic Casodex is made by several different companies, such as:
- Accord Healthcare, Inc.
- Actavis, Inc.
- Sun Pharmaceutical Global, Inc.
- Synthon Pharmaceuticals, Inc.
- Teva Pharmaceuticals
- Zydus Pharmaceuticals.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic Casodex versions currently available have an "AB" rating, meaning they should be equivalent to Casodex.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.